TAU TALKS Trademark

Trademark Overview

On Monday, June 5, 2017, a trademark application was filed for TAU TALKS with the United States Patent and Trademark Office. The USPTO has given the TAU TALKS trademark a serial number of 87475511. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2019. This trademark is owned by Abbvie Inc.. The TAU TALKS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

providing medical information to patients and medical professionals regarding the role of tau in the pathophysiology of Alzheimer's disease
tau talks

General Information

Serial Number87475511
Word MarkTAU TALKS
Filing DateMonday, June 5, 2017
Status700 - REGISTERED
Status DateTuesday, June 18, 2019
Registration Number5783787
Registration DateTuesday, June 18, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesproviding medical information to patients and medical professionals regarding the role of tau in the pathophysiology of Alzheimer's disease

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 12, 2017
Primary Code044
First Use Anywhere DateSaturday, June 23, 2018
First Use In Commerce DateSaturday, June 23, 2018

Trademark Owner History

Party NameAbbvie Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbvie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Tuesday, September 5, 2017NON-FINAL ACTION WRITTEN
Thursday, June 8, 2017NEW APPLICATION ENTERED
Monday, June 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 29, 2017ASSIGNED TO EXAMINER
Tuesday, September 5, 2017NON-FINAL ACTION E-MAILED
Tuesday, September 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 2, 2018NON-FINAL ACTION WRITTEN
Monday, April 2, 2018NON-FINAL ACTION E-MAILED
Monday, April 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 22, 2018FINAL REFUSAL WRITTEN
Monday, October 22, 2018FINAL REFUSAL E-MAILED
Monday, October 22, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 22, 2019TEAS AMENDMENT OF USE RECEIVED
Monday, April 22, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, April 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 23, 2019USE AMENDMENT FILED
Tuesday, April 23, 2019AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, May 7, 2019ASSIGNED TO LIE
Thursday, April 25, 2019USE AMENDMENT ACCEPTED
Thursday, April 25, 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, April 26, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, May 15, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 18, 2019REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, June 18, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

talks medical pathophysiology alzheimer disease role professionals information patients providing regarding